Hemex Health
PrivateLast Round
Debt
Sep 18, 2025
Total Funding Raised
$10.42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hemex Health operates in Healthcare & Life Sciences and is based in Portland, Oregon. Its latest recorded funding round was a Debt round in September 2025.
Hemex Health is a medical device company that develops and commercializes affordable, portable diagnostic technologies for point-of-care testing in remote and challenging settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemex Health Comparables
Compare Hemex Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Molbio Diagnostics | 81% | |
| ShanMukha Innovations Private Limited | 78% | |
| Premier Medical Corporation | 76% |
For institutional investors. Book with your work email.
Hemex Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 18, 2025 | ||||
| Grant | Mar 1, 2024 | ||||
| Grant | Mar 27, 2023 | ||||
| Grant | Aug 1, 2018 | ||||
| Seed | Dec 19, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hemex Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| TiE Global Angels | Seed |
| NIH RADx | Grant |
| Alliance of Angels | Seed |
| National Heart, Lung, and Blood Institute | Grant |
| Elevate Capital | Seed |
| MedAccess | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 120% MoM, reaching 3.1K.
- Jun 2, 2026
Grew 25% quarter-over-quarter, adding 25 employees.
For institutional investors. Book with your work email.
Hemex Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hemex Health's valuation, stock price, and market status.
Is Hemex Health a public or private company?
Hemex Health is a private company.
What is the current stock price of Hemex Health?
Hemex Health is a private company, so its shares have no public market price. Caplight tracks Hemex Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hemex Health worth (valuation)?
Valuation information for Hemex Health is not publicly available.
Can I buy Hemex Health stock?
Hemex Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hemex Health's last funding round?
Hemex Health's most recent funding round was Debt on September 18, 2025.
Who are the main investors in Hemex Health?
Key investors in Hemex Health include National Institute of Allergy and Infectious Diseases, NIH RADx, National Heart, Lung, and Blood Institute, MedAccess.
Will Hemex Health IPO soon?
No public IPO plans have been announced for Hemex Health.
How can I track Hemex Health secondary market activity?
Caplight tracks bids, offers, and trades in Hemex Health's shares on secondary markets.